Failed lung cancer drug trial sends Bristol Myers stock plunging and Merck’s shares up
August 05, 2016 at 08:53 AM EDT
Merck has a rival lung cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.